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The phospholipid PI(3,4)P2 is an apical identity
determinant
Álvaro Román-Fernández 1,2, Julie Roignot3,4,6, Emma Sandilands 1,2, Marisa Nacke1,2,
Mohammed A. Mansour 1,5, Lynn McGarry 2, Emma Shanks2, Keith E. Mostov 3,4 & David M. Bryant 1,2
Apical-basal polarization is essential for epithelial tissue formation, segregating cortical
domains to perform distinct physiological functions. Cortical lipid asymmetry has emerged as
a determinant of cell polarization. We report a network of phosphatidylinositol phosphate
(PIP)-modifying enzymes, some of which are transcriptionally induced upon embedding
epithelial cells in extracellular matrix, and that are essential for apical-basal polarization.
Unexpectedly, we ﬁnd that PI(3,4)P2 localization and function is distinct from the basolateral
determinant PI(3,4,5)P3. PI(3,4)P2 localizes to the apical surface, and Rab11a-positive apical
recycling endosomes. PI(3,4)P2 is produced by the 5-phosphatase SHIP1 and Class-II PI3-
Kinases to recruit the endocytic regulatory protein SNX9 to basolateral domains that are
being remodeled into apical surfaces. Perturbing PI(3,4)P2 levels results in defective polar-
ization through subcortical retention of apically destined vesicles at apical membrane
initiation sites. We conclude that PI(3,4)P2 is a determinant of apical membrane identity.
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The most common cell and tissue type is epithelium. Thesimplest epithelium is a monolayer of cells lining a biolo-gical cavity, such as a lumen. To generate such tissue,
epithelial cells must form distinct cortical domains1. In a proto-
typical epithelium, the apical surface faces the lumen, the lateral
surface interacts with neighboring cells, whereas the basal surface
interacts with the extracellular matrix (ECM). The basal and
lateral domains are contiguous and termed basolateral. The
mechanisms controlling protein delivery to, and maintenance at,
cortical domains in polarized cells have been extensively studied2.
How epithelial cells become polarized and form a lumen de novo
remains poorly understood, yet it is an outstanding problem in
both development and disease.
MDCK cells grown inside ECM to form three-dimensional
(3D) cysts have been widely used as a model system of polar-
ization and lumen formation. In 3D, these undergo stereotyped
morphogenesis, transitioning from a single cell to an apical-basal
polarized monolayer radially organized around a central lumen3.
During this process, each cell generates apical-basal polarization
de novo. A number of polarization mechanisms ﬁrst demon-
strated in MDCK cysts are conserved in vivo4–10. Thus, MDCK
cystogenesis is a powerful reductionist system to study epithelial
polarization.
Upon 3D plating, single-MDCK cells divide into doublets with
inverted polarity; some apical proteins, such as Podocalyxin/gp135
(Podxl), are found at the ECM-abutting surface but excluded from
cell–cell contacts11,12. Integrin-dependent ECM sensing triggers
Podxl endocytosis and transcytosis to the apical membrane
initiation site (AMIS), a zone at doublet cell–cell contacts which
remodels into the nascent lumen13. Remodeling involves conver-
sion of a basolateral domain into an apical protein delivery zone.
This stage is titled the pre-apical patch (PAP)14. The luminal space
expands as the lumen matures. Delivery to the AMIS is regulated
by the Rab11a GTPase. Rab11a inﬂuences molecular motors and
vesicle docking and fusion machinery recruitment to ensure apical
protein delivery to the AMIS12,13,15–17. Therefore, Rab11a-
regulated exocytosis to the AMIS is crucial to generate apical
polarity1.
Phosphatidylinositol phosphate (PIP) asymmetry is essential
for cell polarization18. PIPs can be modiﬁed by reversible phos-
phorylation of the 3-, 4-, or 5-position of their inositol ring19.
Asymmetric PIP production at the cortex, or in organelles,
determines membrane identity by scaffolding distinct PIP-
binding proteins at these locales. In MDCK cysts apical-basal
polarization depends on cortical PIP asymmetry regulated by the
3-phosphatase PTEN11: PI(4,5)P2 is apically enriched, whereas
PIP3 is basolateral. This lead to a model proposing PI(4,5)P2 as an
apical identity determinant; this model is problematic, given that
PI(4,5)P2 is the precursor to PIP3 and is also basolateral11,18.
Whether alternate PIP species may fulﬁll an apical-speciﬁc
function is unknown.
These advances focus attention on the key question of how
existing cell surfaces are remodeled. Speciﬁcally, what controls
cell–cell contact remodeling into an AMIS? We elucidate a
molecular mechanism of de novo polarization through cortical
PIP conversion to promote apical identity.
Results
PIP distribution during de novo apical-basal polarization. De
novo apical-basal polarization in MDCK cysts occurs via ste-
reotyped stages (Fig. 1a)11,12. We examined PIP distribution
during cystogenesis through ﬂuorescent protein-fused PIP-bind-
ing domains20. In cysts with an open lumen, reporters for PI(4,5)
P2 were cortically distributed with apical enrichment, overlapping
with apical Podxl (Fig. 1b, Supplementary Fig. 1a, white
arrowheads). In contrast, reporters for PIP3 were basolateral
(Fig. 1b, Supplementary Fig. 1a, white arrows), conﬁrming pre-
vious results11. The PI(4,5)P2/PIP3 boundary was marked by
Par3/aPKC (Fig. 1b, yellow arrowheads), the latter combination
of which labels the AMIS during lumen initiation12.
To determine when PIP3 asymmetry emerges, we examined
early lumenogenesis. At all stages, Par3 coincides with PIP3
depletion. At the cell doublet stage, after initially peripheral Podxl
internalized and transcytosed near cell–cell contacts, a single-Par3
punctum formed adjacent to each cell–cell contact (Fig. 1c, blue
arrowheads), associated with PIP3 depletion (white arrowheads).
As the AMIS formed, the Par3-positive/PIP3-depleted zone
expanded. At the PAP, PIP3 was further depleted and Par3
relocalized to the PIP3/apical boundary (Fig. 1c, yellow arrow-
heads; Fig. 1b). This required the 3-Phosphatase PTEN, which
localizes to the AMIS during polarity formation21. PTEN
depletion attenuated lumen formation via subcortically stalling
apically destined Podxl vesicles (Supplementary Fig. 1b‒d). Thus,
a PTEN-regulated Par3-positive/PIP3-depleted zone marks the
AMIS, the site for apical vesicle delivery.
We examined PIP content in transcytosing Podxl vesicles.
While demonstrating different localizations, and some adja-
cency to Podxl/Rab11a vesicles, none of PI(3)P, PI(4)P, PI(5)P,
PI(4,5)P2, or PIP3 showed strong localization to apically
destined vesicles at the AMIS (Fig. 1d, yellow arrowheads),
using multiple reporters where possible (Supplementary Fig. 1a,
e-j). In contrast, whereas displaying some nuclear and
cytoplasmic ﬂuorescence, a probe for PI(3,4)P2 (EGFP-2xPH-
TAPP122) overlapped speciﬁcally with Podxl staining at the
apical surface, transcytosing vesicles, and the AMIS (Fig. 1e,
white arrowheads). PI(3,4)P2 may therefore be a regulator of
apical domain function.
PI(3,4)P2 localizes to apical recycling endosome membranes.
We validated EGFP-2xPH-TAPP1 as a bona ﬁde reporter of
apical and recycling endosome PI(3,4)P2. We developed a Pipe-
line for semi-automated phosphoinositide intensity analysis
(PAPI), allowing robust identiﬁcation of differential PIP locali-
zation across hundreds of cyst cultures (Fig. 2a).
EGFP-2xPH-TAPP1 expression, but not a phosphoinositide
binding-deﬁcient mutant (ΔPIP, TAPP1-2xPH-R211L22), was
signiﬁcantly apically enriched, and displayed nuclear recruitment
(Fig. 2b, c), though the latter was not signiﬁcant over
nucleocytoplasmic protein GFP. In contrast, the PIP-mutant
probe enriched basolaterally (Fig. 2c). Antibody staining for
endogenous PI(3,4)P2 displayed similar apical and nuclear
localization (Fig. 2d, e), overlapping with the EGFP-2xPH-
TAPP1 probe at the lumen (Fig. 2f), or periphery in cysts with
inverted polarity (Fig. 2g), and was asymmetric to basolateral
PIP3 (Fig. 2h).
We characterized PI(3,4)P2 localization during polarization
using the EGFP-2xPH-TAPP1 probe which we will now refer to
as PI(3,4)P2. At all stages, PI(3,4)P2 nuclear labeling is observed,
but it will no longer be mentioned for ease of description. In early
cyst development, PI(3,4)P2 showed inverted localization, over-
lapping with peripheral Podxl and with Rab11a underneath apical
membranes (Fig. 3a, b, white arrowheads). As Rab11a-positive
vesicles rearranged towards the AMIS, these showed positivity for
PI(3,4)P2 (Fig. 3a, white arrows, Supplementary Fig. 2a, Supple-
mentary Movie 1) and Podxl (Fig. 3b white arrowheads),
displaying progressive PI(3,4)P2 enrichment closer to the AMIS.
As development proceeded from the PAP to open lumen, two PI
(3,4)P2 pools were apparent: Rab11a-positive endosomes (Fig. 3a,
PAP, white arrows), and the lumen, the latter marked by F-actin/
Podxl (Fig. 3a, b, white arrowhead; Supplementary Fig. 2b,
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Supplementary Movie 2). PI(3,4)P2 is thus a component of apical
membranes and recycling endosomes.
As we saw progressive Rab11a/PI(3,4)P2 enrichment in vesicles
towards the AMIS, we examined whether transcytosing Podxl
transited via other PIP-enriched compartments. While PI(3)P
lacked apparent overlap with Rab11a once lumens formed
(Fig. 3c), PI(3)P-positive compartments (yellow arrowheads)
closely apposed Podxl/Rab11a vesicles not yet clustered near the
AMIS. In these locales occasional triple Rab11a/Podxl/PI(3)P
positivity was observed (white/red arrows). In contrast, PI(4)P
was observed both at the cortex (Supplementary Fig. 1f‒h) and in
Podxl-positive vesicular compartments (Fig. 3c, yellow/magenta
arrows), which were separated from Rab11a-/Podxl-positive
endosomes (white/red arrowheads). Instead, PI(4)P-positive
structures were always adjacent to Rab11a. Podxl may pass
through PI(3)P/PI(4)P-positive endosomes en route to the AMIS.
PI(3,4)P2 has emerged as a regulator of clathrin-dependent and
-independent endocytosis23–25. We observed that caveolin-1, but
not clathrin heavy chain (CHC), co-localized extensively with PI
(3,4)P2 at the apical membrane at all stages (Fig. 3d, white
arrowheads; Supplementary Fig. 2c, d), a site where the former
overlaps with Cavin-1 (Supplementary Fig. 2e). Though intracel-
lular caveolin-1 and PI(3,4)P2 puncta occurred, these did not
overlap (Fig. 3d, yellow arrowheads). These data reveal Rab11a
and Caveolin-1, as markers of endosomal or apical pools of PI
(3,4)P2, respectively.
PIP-modifying enzyme networks control polarization. PIPs are
made through combinatorial, reversible phosphorylation events19
(Fig. 4a). We examined known PIP-modifying enzyme expression
during polarization (Fig. 4b). 3D embedding of MDCK induces
transcriptional reprogramming to express machinery required for
3D polarization15. We reasoned that this might extend to PIP-
modifying enzymes. Comparison between monolayers (2D) and
3D cysts (23 h, 48 h) revealed extensive transcriptional changes to
PIP-modifying networks, in a temporal fashion in 3D (Fig. 4b,
Supplementary Fig. 3a). We performed functional
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Fig. 1 PIP distribution during polarization. a Cartoon of cyst development, showing progression from single cell through inverted doublet, transcytosing
vesicles/AMIS (Apical Membrane Initiation Site), PAP (Pre-apical Patch) and Open Lumen stages. Red, apical/Podxl; black, basolateral. b PI(4,5)P2 [EGFP-
PH-PLC] and PI(3,4,5)P3 [PIP3, EGFP-PH-Grp1] (both green) localization in MDCK cysts with an open lumen (48 h), stained for Podxl (red) and either Par3
(left) or aPKC (right) (both blue or inverted greyscale). White arrowhead (red in inverted color panels), apical PI(4,5)P2; white arrows (red in inverted color
panels), basolateral PIP3; yellow arrowheads, tight junction-localized Par3 or aPKC. In all instances, bottom panels are higher magniﬁcation of split color
images from boxed regions. c PIP3 [EGFP-PH-Grp1], Podxl and Par3 localization during lumen initiation (12–24 h). Note the single Par3 punctum forming
adjacent the cell–cell contact in each cell (blue arrowheads). White arrowheads (red in inverted color panels), edge of PIP3-enriched PM; yellow
arrowheads, tight junction-localized Par3. PIP3 in magniﬁed boxes has been pseudocoloured to indicate intensity of labeling. d PI(3)P [EGFP-2xFYVE], PI(4)
P [EGFP-PH-FAPP1], PI(5)P [EGFP-PH-ING2], PI(4,5)P2 [EGFP-PH-PLC] and PIP3 [EGFP-PH-Grp1] localization in cysts at the AMIS stage, stained for Podxl
and either β-catenin (panels 1 and 3) or Rab11a (panels 2, 4, 5). Note the PI(3)P vesicles forming below the cell–cell contact near the β-catenin-depletion
site (white arrow) and the absence of each PIP in Podxl-positive vesicles (yellow arrowheads). White arrowheads, PIP localization. e PI(3,4)P2 [EGFP-
2xPH-TAPP1] localization in MDCK cells at the AMIS stage, stained with Podxl and β-catenin. Arrowheads, Podxl at ECM-abutting surface and AMIS. Far
right panels are higher magniﬁcation of split color images from the boxed region. All scale bars, 10 µm
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characterization of 5-phosphatases that might produce apical PI
(3,4)P2, INPP5E, SHIP1, and OCRL (Fig. 4b, red).
OCRL1-mCherry showed vesicular labeling with little over-
lap with Podxl at the AMIS or once lumens had formed
(Supplementary Fig. 3b, yellow arrowheads). SGFP2-INPP5E
localized to a single punctum, occurring in the center of
transcytosing Podxl vesicles, then juxtaposing the AMIS/PAP
(Supplementary Fig. 3c, e, yellow and white arrowheads),
before becoming localized to cilia and subapical puncta once
lumens formed (Supplementary Fig. 3d). INPP5E depletion
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attenuated lumen formation (Supplementary Fig. 3f‒h), but not
apical-basal polarization in ﬁlter-grown 2D monolayers
(Supplementary Fig. 4a). As neither OCRL or INPP5E localize
at the AMIS or show overlap with Podxl, it is unclear how it
controls PIP3 > PI(3,4)P2 conversion. We thus turned our
attention to SHIP1.
SHIP1 converts a cell–cell contact into an AMIS. SHIP1 is a 5-
phosphatase that converts PIP3 into PI(3,4)P226, thereby trig-
gering PI(3,4)P2-dependent fast endophilin-mediated
endocytosis23. SHIP1 showed robust, early upregulation in 3D
(Fig. 4b). During polarization, SHIP1-EGFP co-localized with β-
catenin-positive basolateral domains (Fig. 4c, blue arrowheads),
becoming excluded from the forming lumen at the PAP stage
(yellow arrowheads). Unexpectedly, after lumen formation,
SHIP1-EGFP relocalized apically (yellow arrowheads). SHIP1
dynamic relocalization thus coincides with cortical depletion of
its substrate, PIP3.
We inhibited SHIP1 by chemical and genetic means. To ensure
robust polarity phenotype detection, we built a Pipeline for semi-
automated polarity analysis, PAPA, quantifying hundreds to
thousands of cysts per condition (Supplementary Fig. 4b), and
performing comparably to manual quantitation (Supplementary
Fig. 1c). SHIP1 chemical inhibition27 at the time of plating strongly
disrupted lumen formation, causing subcortical apical vesicle
retention (Fig. 4d, Supplementary Fig. 4c). In contrast, chemical
inhibition of SHIP1 after lumens formed failed to perturb cell
polarity (Fig. 4d), in line with requirement to convert basolateral
PIP3 to PI(3,4)P2 only during AMIS formation. Endogenous SHIP1
depletion resulted in similar phenotypes (Fig. 4e–g). Control cysts
displayed luminal Podxl (Fig. 4h, blue arrowheads), PIP3 reporter or
β-catenin at basolateral membranes, and Par3 at the boundary
between these zones (Fig. 4h, yellow arrowheads). SHIP1 depletion
resulted in defective lumen formation and aberrant retention of
PIP3, Par3, and β-catenin adjacent to rudimentary lumens (Fig. 4h,
white arrowheads). SHIP1 PI(3,4)P2-producing activity was
required as only expression of RNAi-resistant WT, but not
phosphatase-deﬁcient, SHIP1 reversed SHIP1 depletion phenotypes
(Fig. 4h, i). In contrast, ﬁlter-grown 2D monolayers displayed no
defects in apical-basal polarization upon SHIP1 depletion (Supple-
mentary Fig. 4a). SHIP1 is therefore a regulator of de novo apical
membrane biogenesis in 3D.
We utilized PAPI to examine cortical PIP [PI(4)P, PI(3,4)P2, PI
(4,5)P2, and PIP3] level and distribution after SHIP1 inhibition
(Fig. 5a–d). This conﬁrmed exclusive localization of apical PI(3,4)
P2, cortical with apical enrichment PI(4)P and PI(4,5)P2, and
basolateral PIP3 (Fig. 5a–d). SHIP1 inhibition caused a
signiﬁcant, localized response, increasing basolateral PIP3
(Fig. 5b). We examined whether attenuating PIP3 generation
(Class-I PI3-Kinase inhibition) could reverse the effect of PIP3
stabilization (SHIP1 inhibition). PI3-kinase inhibition (PI3K-i)
has pleiotropic effects in 3D, as PIP3 regulates growth and
polarity orientation28–31, but also must be depleted at the AMIS.
Class-I PI3K inhibition increases lumen formation in a popula-
tion of cysts which display smaller size, and inversion of polarity
in another pool (Fig. 5e–h). Consistent with a role in stabilizing
PIP3 levels, SHIP1 inhibition (SHIP1-i) signiﬁcantly increased
cyst size, attenuated lumen formation and caused a mild, though
signiﬁcant, increase in polarity inversion. Combined SHIP1/PI3K
inhibition failed to rescue polarity inversion, but completely
rescued effects of SHIP1 on lumen formation and a signiﬁcant,
partial rescue of size (Fig. 5e–h). Regulation of basolateral PIP3
levels, and its metabolism into PI(3,4)P2, are therefore essential to
form a lumen de novo.
We examined whether exogenous PI(3,4)P2 supply would
promote lumen formation (Fig. 5i). Strikingly, addition of
exogenous PI(3,4)P2 to cysts signiﬁcantly increased lumen
formation without affecting polarity inversion, but only if
SHIP1 was not inhibited. Thus, while AMIS-localized PI(3,4)P2
generation promotes lumen formation, co-depletion of PIP3 is
essential.
Class-II PI3-kinases contribute to apical polarization. Follow-
ing PIP3 to PI(3,4)P2 conversion at the AMIS, SHIP1 was dis-
pensable for polarity (Fig. 4d). We examined the contribution of
the endosomal PI(3,4)P2 pool to lumen formation. PI(3,4)P2 can
also be generated from PI(4)P by Class-II PI3-kinases24,32. We
noted upregulation of PIK3C2G in 3D, and downregulation of
PIK3C2A/B (Fig. 4b). Unexpectedly, PIK3C2A and PIK3C2B
depletion perturbed lumen formation, whereas depletion of
PIK3C2G modestly promoted lumen formation (Fig. 6a–c).
PIK3C2A/B co-depletion robustly inhibited lumen formation
(Fig. 6a–c). Thus, PIK3C2A/B are non-redundant lumen forma-
tion regulators.
PIK3C2A/B displayed distinct localizations, though both
overlapped with different pools of Rab11a. GFP-PIK3C2A was
closely associated with Rab11a vesicles throughout polarization
(Fig. 6d). A pool of GFP-PIK3C2B was basolateral and
Fig. 2 Validation of PI(3,4)P2 localization. a Schematic representation of a Pipeline for semi-automated phosphoinositide intensity analysis, PAPI. MDCK
cysts stably expressing GFP-tagged PIP reporters were cultured in 3D for 48–72 h, ﬁxed and stained with Podxl to mark the apical domain, Phalloidin the
cortex, and Hoescht the nucleus. Confocal optical sections of MDCK cysts were imaged and automated processing selected the medial plane based on the
maximum lumen area. Separated cyst regions were deﬁned based on differential localization of the above markers. PIP probe intensity was measured in
each domain, followed by mathematical and statistical analysis to extract the relative PIP probe intensity ratio within compartments of the same object
(cyst). b Cysts at the open lumen stage expressing either EGFP-2xPH-TAPP1 (WT) or a mutant EGFP-2xPH-TAPP1 unable to bind PI(3,4)P2 (ΔPIP), stained
for F-actin (red) and nuclei (blue). Luminal (white arrowheads), basolateral (yellow arrowheads), and nuclear (red arrowheads) localization is highlighted
in magniﬁed ﬁelds. c Quantitation of relative apical to cytoplasm (left), basolateral to total (center) or nuclear to total (right) PIP reporter intensity
compared to GFP-overexpressing control MDCK cells. Box-and-whiskers: 10–90 percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles.
n≥ 208 cysts assessed from three wells/condition/experiment, three independent experiments (2 for EGFP-2xPH-TAPP1 WT clone 2). P-values (One-way
ANOVA): *P≤ 0.05, **P≤ 0.005, ***P≤ 0.0001. d, e Forty-eight hours MDCK cysts stained for endogenous PI(3,4)P2 (greyscale or green), F-actin (red)
and nuclei (blue) using four different ﬁxation and staining protocols, i43, ii12, iii24, iv44. Note that PI(3,4)P2 can be observed at the luminal domain in all
cases (magenta arrowheads). Nuclear localization was also detected in some conditions (iv, e, yellow arrows). f Sequential optical sections of the medial
region of an MDCK cyst expressing EGFP-2xPH-TAPP1 (green) stained for endogenous PI(3,4)P2 (red). Note co-localization in the luminal membrane
(white arrowheads) and nuclei. g Inverted polarized MDCK cyst expressing EGFP-2xPH-TAPP1 (green) stained for PI(3,4)P2 (red) and Hoescht (blue).
h Forty-eight hours MDCK cyst expressing a probe for PIP3 [EGFP-PH-Grp1, green] stained for endogenous PI(3,4)P2 (red and greyscale) and Hoescht
(blue). Yellow arrowheads, basolateral. Magenta arrowheads, luminal. All scale bars, 10 µm
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overlapped with clusters of Rab11a that were close to the cortex
(Fig. 6d, e). GFP-PIK3C2B was initially at doublet cell–cell
contacts, but became progressively removed from the forming
AMIS (Fig. 6f). In cysts with an open lumen, GFP-PIK3C2B
could be seen both at the basolateral membrane and in vesicular
compartments near Rab11a. Thus, PIK3C2A is constitutively
Rab11a-endosome adjacent, while PIK3C2B may be involved in
cortical Rab11a events controlling apical polarization.
We examined whether PIK3C2A/B could counteract SHIP1
inhibition. Despite both kinases being required for lumen
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formation (Fig. 6a–c), only GFP-PIK3C2A overexpression
increased lumen formation, similar to Rab11a overexpression12,
and rescued SHIP1 inhibition (Fig. 6g). Thus, PIK3C2A/B may
promote lumen formation from different pools, with the Rab11a/
PIK3C2A pool increasing de novo apical domain generation.
INPP4A/B are negative regulators of apical polarization. As
lumen formation efﬁciency could be both increased and
decreased, we looked for potential tonic PI(3,4)P2 regulators. The
4-phosphatases INPP4A/B, which can convert PI(3,4)P2 to PI(3)
P33, were initially downregulated in 3D, with INPP4A re-induced
at 48 h (Fig. 4b). Ectopic expression of INPP4B signiﬁcantly
attenuated single lumen formation, causing subcortical Podxl
vesicle accumulation, in a phosphatase-dependent fashion
(Fig. 7a–c). Conversely, depletion of INPP4A/B alone or together
increased lumen formation (Fig. 7d–f), mirroring PIK3C2A
overexpression (Fig. 6g). Unlike PIK3C2A overexpression how-
ever, INPP4A/B depletion alone or together failed to rescue the
effect of SHIP1 inhibition (Fig. 7f). Thus, transcriptional down-
regulation of PI(3,4)P2-depleting enzymes is essential for de novo
lumenogenesis.
The apical Par complex is PI(3,4)P2-independent. We aimed to
identify the functional consequence of apical PI(3,4)P2 genera-
tion. The PTEN-mediated production of apical PI(4,5)P2 from
PIP3 controls the function of the aPKC/Par6/Cdc42 module in
association with apical Annexin211. In contrast, SHIP1-mediated
PI(3,4)P2 production did not affect aPKC level or activation
(Fig. 8a), Annexin2 apical, cortical or apical-basal localization
ratio (Fig. 8b, c), recruitment of Cdc42 onto Podxl/Rab11a-
positive vesicles (Fig. 8d), activation levels of Cdc42 at the apical
membrane (Fig. 8e) or recruitment of WT or mutationally active
Cdc42 to the cortex, to the apical domain or the apical-basal ratio
(Fig. 8f). Thus, production of PI(3,4)P2 from PIP3 at the AMIS by
SHIP1 does not regulate the apical aPKC/Cdc42/Par3 complex.
PI(3,4)P2-SNX9 interaction is essential for lumen formation.
To identify PI(3,4)P2-interacting protein(s) regulating polariza-
tion, we examined whether INPP4B overexpression disrupted
known PI(3,4)P2 interactor localization24. We focused on labeling
endogenous proteins, to preclude counteraction of INPP4B
overexpression by exogenous effector protein co-overexpression.
We detected that endogenous SNX9, a protein involved in PI(3,4)
P2-dependent endocytosis, was present in subapical puncta that
were lost upon INPP4B overexpression (Fig. 9a). Depletion of
SNX9 phenocopied SHIP1 depletion or INPP4B overexpression,
resulting in subcortical Podxl accumulation and defective lumen
formation (Fig. 9a–c). Unlike WT SNX9 expression, PI(3,4)P2
binding-deﬁcient SNX9 mutants24 failed to reverse the effect of
SNX9 depletion (Fig. 9d–f). Combining SNX9 depletion with
PIP-binding-deﬁcient SNX9 expression caused subcortical vesi-
cular accumulation of non-overlapping pools of Podxl and β-
catenin, but both of which did overlap with mutant SNX9.
Therefore, the formation of PI(3,4)P2 at the AMIS is essential for
SNX9 to remodel basolateral components to form an apical
domain de novo.
Discussion
We describe a transcriptionally regulated PIP-modifying enzyme
network essential for lumen formation. Notably, the enzymes
required in 2D and 3D are not interchangeable, though both
conditions are apical-basal polarized. This revealed an unantici-
pated role for the PI(3,4)P2 as a determinant of 3D apical identity.
Speciﬁc to the 3D context is basolateral cell–cell contact remo-
deling into an apical domain12. Several PIP-modifying enzymes
participate in this process.
The doublet cell–cell contact contains a PI→PI(4)P→PI(4,5)
P2→PIP3 cascade that generates basolateral identity (for model,
see Fig. 10a–c). During polarity rearrangement, PTEN locally
reverses the last step in the PIP3 cascade, inducing a PIP3
depletion zone: the AMIS11,21 (Fig. 10b). Due to this early apical
enrichment, PI(4,5)P2 was described as an apical targeting fac-
tor34. However, PI(4,5)P2 is also basolateral. Our current data
suggest an updated model wherein lack of PIP3, rather than the
mere presence of PI(4,5)P2, encodes part of apical identity.
We report that the long-unidentiﬁed apical domain identity
determinant is PI(3,4)P2, which is enriched apically and on
recycling endosomes. That PI(3,4)P2 is asymmetric in localization
and function to PIP3 is unexpected. PI(3,4)P2 was considered as
part of PIP3 signaling cascades, given that both lipids bind the
Akt PH domain in vitro35. Such studies have examined PI(3,4)P2
in single or poorly polarized cells, where apical domains may not
occur. The functions and asymmetry of PI(3,4)P2 may have been
underappreciated in such contexts.
How is PI(3,4)P2 generated? At least two pools of PI(3,4)P2
exist and these dynamically rearrange during polarization:
Rab11a endosomes and apical surfaces. In early cell doublets
(Fig. 10a), PI(3,4)P2 is enriched at the periphery with apical
proteins. As polarity reorientation is triggered, Podxl-positive
vesicles transcytosed to the AMIS. These vesicles initially contain
PI(3)P/PI(4)P, before enriching with PI(3,4)P2 and Rab11a as
Podxl clusters at the AMIS. The class-II PI3-kinases PIK3C2A/B,
which generate PI(3,4)P2 from PI(4)P in other contexts24,32, may
promote formation of endosomal PI(3,4)P2, though acting in
different locales: PIK3C2B localizes with Rab11a puncta close to
the cortex, whereas PIK3C2A localizes closely opposed to trans-
cytosing Rab11a. Rab11a and PIK3C2A likely co-operate to
promote PI(3,4)P2 as overexpression of either, or exogenous
supply of PI(3,4)P2, increases lumen formation rates. Indeed,
PIK3C2A controls Rab11a activation in other systems36. It is
Fig. 3 PI(3,4)P2 is an apical- and recycling endosome-enriched lipid. a, b PI(3,4)P2 localization during different stages of lumen formation (12–48 h) in
MDCK cells stably co-expressing EGFP-2xPH-TAPP1 [PI(3,4)P2 sensor, green] and either a TagRFPT-Rab11a WT (red) and stained for F-actin (blue), or
b Podxl (red) and stained for β-catenin (blue). White arrows, PI(3,4)P2 co-localization with Rab11a vesicles at all stages; white arrowheads, cortical PI(3,4)
P2 localization; red arrowheads, PI(3,4)P2-positive, Podxl-negative vesicles below the cell–cell contact at the AMIS stage; yellow arrowheads, PI(3,4)P2
present at low levels at the basolateral PM at the AMIS stage. In all instances, bottom panels are higher magniﬁcations of split color images from the boxed
regions. c Localization of Rab11a (TagRFPT-Rab11a, left; endogenous antibody staining, right; both red) in either 24 or 48 h cysts in relation to either PI(3)P
[EGFP-2xFYVE, top] or PI(4)P [EGFP-P4M-SidM, bottom] (both green). In blue, Podxl (left panel) or nuclear staining (right panel). Yellow arrowheads,
Rab11a-negative PIP reporter vesicles. White arrowheads (red in inverted color panels), Rab11a endosomes. White arrows (red in inverted color panels),
triple Rab11a/Podxl/PIP reporter-positive vesicles. Yellow arrows (magenta in inverted color panels), Rab11a-negative, Podxl/PIP reporter-positive vesicles.
Pink arrows, Rab11a/PI(4)P overlapping endosomes. d PI(3,4)P2 and caveolin-1 localization during lumen formation (12–48 h) in EGFP-2xPH-TAPP1 (green)
MDCK cells stained with Caveolin-1 (red). Note the cortical co-localization of Caveolin-1 and PI(3,4)P2 at all stages (white arrowheads) and the absence of
intracellular co-localization (yellow arrowheads). All scale bars, 10 µm
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important to note that INPP4A/B, which can decrease PI(3,4)P2
through conversion to PI(3)P35, were transcriptionally down-
regulated in 3D during the developmental window of apical
vesicle transcytosis. Ectopic re-expression of INPP4B disrupts
apical polarization in a phosphatase-dependent fashion. Con-
comitant with transcytosing apically destined vesicles, tran-
scriptionally upregulated SHIP1 is responsible for the initial
conversion of basolateral PIP3 at the AMIS into PI(3,4)P2. Once
this event occurs, SHIP1 is now dispensable for polarity, and the
apical enrichment of PI(3,4)P2 is likely reinforced by delivery of
PI(3,4)P2-positive Rab11a vesicles.
PTEN can also function as a PI(3,4)P2 phosphatase37. Given
that PTEN is enriched at the forming AMIS21, whether it is acting
solely on PIP3 or also on PI(3,4)P2 is unknown. If both are
occurring, the AMIS localization of PIK3C2B may help to focally
reverse this dual speciﬁcity, leading to co-enrichment of apical PI
(4,5)P2 and PI(3,4)P2. The exact function of PTEN at the AMIS
thus warrants further attention.
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What is the function of apical PI(3,4)P2 in 3D polarization?
In contrast to PTEN-mediated PIP3 to PI(4,5)P2 conversion,
SHIP1-mediated PIP3 to PI(3,4)P2 conversion did not affect
apical aPKC-Cdc42 activity. In cells in 2D, PI(3,4)P2 regulates
cell motility, and both clathrin-dependent and -independent
endocytosis23–25,38,39. In our system, apical PI(3,4)P2 most
closely overlapped with Caveolin-1, and not clathrin, suggest-
ing a clathrin-independent pathway may remodel basolateral
cargo proteins through endocytosis to allow the AMIS to
form. Accordingly, perturbing PI(3,4)P2 levels or its interaction
with SNX9 results in the subcortical vesicular localization
of both apical and basolateral cargoes. One function of cortical
PI(3,4)P2, in addition to promoting a zone for apical exocy-
tosis, may be to promote endocytosis of basolateral proteins at
the AMIS. The function of recycling endosome-localized PI
(3,4)P2 is unknown, but may be to recruit other sorting nexins,
such as the apical exocytosis-promoting SNX9 homologue,
SNX1817.
If PI(3,4)P2 is both in recycling endosomes and the apical
domain, how can it be an apical determinant? It may be that
discrimination between these two PI(3,4)P2-positive compart-
ments is provided by the absence or presence of PI(4,5)P2,
respectively. Such a combinatorial PIP code for membrane
identity greatly expands the possible number of compartment
identities than can be generated by the seven PIPs alone. In line
with this, although exogenous addition of PI(3,4)P2 enhanced
lumen formation efﬁciency, it could only do so when SHIP1 was
functional. The apical identity code may therefore be the presence
of PI(3,4)P2 and PI(4,5)P2, and the absence of PIP3. In support of
this, exogenous PIP3 addition to an apical membrane causes rapid
conversion to basolateral identity28. The recycling endosome code
may rather be PI(3,4)P2 without PI(4,5)P2.
Our studies underpin that whereas there are in theory multiple
ways to make a PIP, these are transcriptionally and spatio-
temporally regulated during development. What is important to
note is that PIP production and morphogenesis go hand-in-hand:
inhibiting SHIP1-mediated PIP3 to PI(3,4)P2 conversion results
in basolateral domains with more PIP3, but not with apical
domains with less PI(3,4)P2. Rather, an apical domain will not
form if sufﬁcient apical PI(3,4)P2 is not generated, or if cortical
PIP3 is not removed. This represents a conceptual difference from
2D studies where the cortex is a constant structure where PIP
levels can change. In multicellular 3D contexts, such changes in
cortical PIP levels induces alternate morphogenesis, such as
conferring apical or basolateral identity.
In addition to their function in cell polarization, phosphoino-
sitides participate in cell growth and survival pathways18,40. For
instance, correct cell polarization may lay upstream to decisions
of cell death or survival during morphogenesis. Likewise, per-
turbation of PIP-modifying enzymes, such as the PTEN or
INPP4B loss observed in cancer40,41, may be facilitative of the
disrupted polarity and overgrowth of tumors. The extent to which
these processes are distinct pathways or are intimately linked
remains unclear.
We describe an unappreciated function of PI(3,4)P2 in apical
domain morphogenesis in MDCK cysts. Although an in vitro
reductionist system, the molecular mechanisms elucidated in
MDCK cysts have been demonstrated as conserved in a variety of
other systems4–9. Yet, there are several developmental mechan-
isms for lumen formation; the polarized exocytosis and mem-
brane remodeling we describe here can be bypassed by apoptotic
cavitation of multicellular clusters or folding and joining of tissue
sheets1,42. In these instances, we predict that apical PI(3,4)P2 is
likely supplied by the endosomal pool, rather than conversion
from basolateral PIP3 by SHIP1. In spite of differences in the way
it can form, the apical domain is essential for exchange of pro-
teins, nutrients, solutes and lipids. Given, for example, that the
kidney lumen is an extremely active site of endocytosis in vivo,
that PI(3,4)P2 has emerged as a regulator of rapid endocytosis
aligns with such a physiological requirement23–25. It will thus
now be important to determine the involvement and regulation of
apical and recycling endosome PI(3,4)P2 in development and
disease.
Methods
Cell and cyst culture. MDCK-II (K.Mostov, UCSF) cells were grown in 5% fetal
bovine serum (FBS; Gibco) in minimum essential medium (MEM, Gibco). 293-FT
cells (Thermo Fisher Scientiﬁc) were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Gibco) supplemented to ﬁnal 10% FBS, 0.1 mM non-essential
amino acids, 1 mM sodium piruvate and 6 mM L-glutamine. 293 GPG cells were
grown in DMEM supplemented to ﬁnal 10% heat-inactivated FBS, 2 mM L-Glu-
tamine, 20 mM HEPES, 1 µg ml−1 tetracycline (Sigma T-7660) and 2 µg ml−1
puromycin (Sigma P-7255) (K.Mostov, UCSF) Culture of MDCK-II as 3D cysts
was adapted from previous protocols13. Brieﬂy, single cell suspensions of 1.5 × 104
cells ml−1 in medium containing 2% Matrigel (BD Biosciences) were plated either
onto 8-well coverglass chambers (Nunc, LabTek-II) or 96-well black bottom plates
(Greiner, SLS); 300 or 150 μl total, respectively), pre-coated with 5 μl of Matrigel
(100%). For SHIP1 inhibition experiments, cells were treated from the time of
plating, unless otherwise speciﬁed, with either 5 μM SHIP1 inhibitor (3AC, Cal-
biochem) or ethanol as a control. For Type I-PI3K inhibition experiments, cells
were treated from the time of plating with 10 µM of type I-kinases inhibitor
(LY294002, Calbiochem) or DMSO as a control. DNA lipofection or viral infection,
followed by antibiotic selection for 1–3 weeks and FACS to obtain appropriate
expression was used to generate stable lines of ectopic protein expression. Selective
antibiotics were removed 24 h prior to 3D culture. For cells stably expressing
EGFP-2xPH-TAPP1, 2 subclones with low cytoplasmic background were studied.
Antibodies and immunocytochemistry. Cysts immunolabelling was adapted from
previously described protocols12: Cultures were ﬁxed in 4% paraformaldehyde
(PFA, Afﬁmetrix) for 5–15 min at room temperature (RT), washed twice in PBS,
Fig. 4 SHIP1 converts PIP3-rich basolateral membrane into apical domains. a Conversion between the phosphoinositide species, all derived from
phosphatidylinositol (PI), occur via the action of kinases (in green) and phosphatases (in red). Dashed arrows, pathway whose occurrence or regulatory
enzyme is still unknown. b Heat map of Manhattan-clustered, differentially expressed PIP kinases and phosphatases in cells grown as a monolayer for 48 h
or as cysts in Matrigel for 23 or 48 h. Relative mRNA expression levels (log2 values), and clustering categories, are shaded as indicated. Four independent
experiments. c SHIP1 localization during lumen formation in MDCK cells expressing SHIP1-EGFP (green) and stained for Podxl (white) and β-catenin or F-
actin (red). d Quantitation of cyst phenotypes treated with ethanol control or SHIP1 inhibitor either at the time of plating (d0) and ﬁxed at day 3 (3 day,
left), or treated at day 3 (d3) and ﬁxed at day 5 (5 day, right). Values are mean ± s.d. For 3 day, n≥ 300 cysts assessed from three wells/condition/
experiment, four independent experiments, P-values (two-way ANOVA): **P≤ 0.001, ***P≤ 0.0001). For 5 day, n≥ 1900 cysts assessed from three wells/
condition/experiment, three independent experiments. e RNA extracts from MDCK cells stably expressing scramble or SHIP1 shRNA were analyzed by RT-
qPCR to detect SHIP1 mRNA levels (n= 1 well per condition, from four independent experiments). P-value (Student’s t-test): *P≤ 0.05. f, gWestern blot of
WT and phosphatase-dead SHIP1 and GAPDH in total cell lysates of parental (MDCK) or SHIP1-EGFP-expressing cells expressing scramble or
SHIP1 shRNA f, and quantitation of cyst phenotypes g. Mean ± s.d., n≥ 400 cysts from four wells/condition/experiment. P-values: two-way ANOVA):
*P≤ 0.05, **P≤ 0.001, ***P≤ 0.0001. h PIP3 [EGFP-PH-Grp1], Podxl and Par3 (left panels) or β-catenin (right panels) localization in cysts expressing
scramble or SHIP1 shRNA. Yellow arrowheads, Par3 (left panels) or β-catenin (right panels); blue arrowheads, Podxl. White arrowheads, overlap of apical
and basolateral domains. i Immunolabelling of above conditions, with Podxl and β-catenin. Two independent experiments for parental MDCK versus SHIP1-
EGFP WT cells and one experiment for parental MDCK cells versus SHIP1-EGFP WT cells or SHIP1-EGFP phosphatase-dead cells. Scale bars, 10 µm
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blocked for 1 h in PFS buffer (PBS, 0.7% w/v ﬁsh skin gelatin (Sigma-Aldrich),
0.5% saponin (Sigma-Aldrich)), and incubated with primary antibodies diluted in
PFS at 4 °C overnight with gentle rocking. Then, cyst cultures were washed thrice
with PFS and incubated with secondary antibodies diluted in PFS for 1 h at RT,
followed by washing twice in PFS and twice in PBS. Primary antibodies are as
described below. Alexa ﬂuorophore-conjugated secondary antibodies (1:250) or
Phalloidin (1:200) (both Invitrogen) and Hoescht to label nuclei (10 μg ml−1), were
utilized. For validation of endogenous PI(3,4)P2 staining in 3D, we optimized
staining protocols. We tested four staining protocols in addition to the commer-
cially recommended protocol (PI(3,4)P2 Ab, Echelon, Z-P034), (i)43, (ii)12, (iii)24,
(iv)44. Buffer four produced endogenous labeling patterns mirroring EGFP-2xPH-
TAPP1 and was used for all further PI(3,4)P2 staining. Brieﬂy, staining in buffer
four is as follows: cysts were ﬁxed in 4% PFA followed by three washes in glycine
buffer (100 mM glycine in PBS), and two washes in PBS. Cysts were permeabilized
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in glycine buffer containing 0.1% of saponin for 20 min, and blocked in PBS
containing 10% fetal calf serum and 0.1% saponin. Primary and secondary anti-
body incubation in blocking buffer were performed in the conditions speciﬁed
above, followed by three washes in blocking buffer. List of used antibodies, in
Supplementary Table 1.
Image acquisition and analysis, PAPA and PAPI. Confocal images were acquired
either on Zeiss LSM 880 Airyscan confocal microscope, a Zeiss LSM 510 confocal,
or an Opera Phenix Z9501 high-content imaging system (PerkinElmer). 3D culture
has the imaging challenge of sparsely positioned objects (cysts) that can be posi-
tioned in different Z-planes. This has previously required manual imaging of each
object, precluding large sample number analyses. We have overcome this by
building two analysis pipelines to allow quantitation of cyst phenotypes or phos-
phoinositide distribution from hundreds to thousands of 3D cysts per condition:
(1) a Pipeline for semi-Automated Polarity Analysis, PAPA, and (2) a Pipeline for
semi-Automated Phosphoinositide Intensity analysis, PAPI. PAPA and PAPI make
use of an Opera Phenix Z9501 high-content imaging system (PerkinElmer). To
direct imaging only to cysts (and not the surrounding non-cyst areas) we used the
PreciScan module (PerkinElmer) to scan entire wells to ﬁnd cysts by
performing z-stacks of each well at ×5 magniﬁcation, on-the-ﬂy processing of
images using user-deﬁned rules to identify cysts, and then directing the microscope
to perform high-resolution z-stacks of objects (cysts). In the case of PAPI, this
requires cysts to express GFP-tagged PIP probes above a baseline level deﬁned as
optimum for imaging. At this step, we perform at least 8 optical sections every 2
µM, imaging at least 25 ﬁelds or objects (×20 and ×63, respectively). For PAPA,
cysts are stained for apical marker (Podxl), the cortex (Phalloidin), whole-cell stain
(cytoplasm), and nuclei (Hoescht). For PAPI, GFP-tagged PIP reporters were
imaged in place of whole cell stain. For PAPA, as lumens can occur in different Z-
planes of a given cyst, a maximum projection of the medial Z-planes was applied.
Using Harmony imaging analysis software (PerkinElmer), user-deﬁned phenotype
classiﬁcation rules to detect polarity orientation based on the localization and
intensity of apical markers and the detection and quantiﬁcation of number of
lumens was applied to each cyst. For benchmarking of accuracy, PAPA was
compared to manual imaging and counting of polarity phenotypes for control vs
SHIP1-inhibited cysts. PAPA produced concordant quantitation of phenotypes to
expert manual quantitation.
For PAPI, as maximum projection of different Z-planes could introduce
quantiﬁcation artefacts, analyses were performed only on the most medial Z-plane,
which was automatically calculated based on the maximal luminal area. To detect
PIP probe intensity in different subcellular locales, cysts were ﬁxed and stained
with Podxl to mark the apical domain, Phalloidin to mark the cortex, and Hoescht
to mark the nucleus. Combinations of these stainings were used to create masked
regions to calculate mean total, cortical, apical, basolateral, cytoplasmic (excludes
nuclear region), and nuclear intensity per area in each region. For depiction of
these regions, see Fig. 2a. Note that for all images taken at super-resolution for
subcellular analysis, such as co-localization between Rab11 and PIPs or PIP-
modifying enzymes, a Zeiss LSM 880 Airyscan confocal microscope was used from
a single plane only. Statistical analysis was performed to calculate percentages of
polarity phenotypes, normalized to control, and the relative PIP intensity in
different cellular regions. Data were processed using KNIME analytics platform,
and GraphPad Prism to generate graphs.
Statistics. Cyst phenotypes were binned into four categories: (a) single lumen, (b)
multiple lumens/vesicular accumulation of Podxl, (c) inverted polarity, (d) other/
no lumen. Relative percentages were normalized to control. For RNAi rescue
experiments, only cysts expressing exogenous transgene were scored. Relative
percentages from each category were normalized to control. Values are mean ± S.D.
from 3 to 9 replicate experiments, with n ≥ 300 cysts per replicate, unless otherwise
indicated. For qPCR, expression was normalized as fold change (log2) from the
mean expression for all conditions. Signiﬁcance was calculated using a paired, two-
tailed Student's t-test, Mann–Whitney test, one-way ANOVA or two-way ANOVA
test. No statistical methods were used to predetermine the sample size. No ran-
domizations were used. The investigators were not blinded to allocation during
experiments and outcome assessment. Statistical tests used are stated on every
ﬁgure legend with P-values as appropriate. Data distribution should meet the
normal distribution requirements. No estimate of variation. Data were analyzed
using KNIME analytics platform, Excel (Microsoft) or Prism (Graphpad).
Live cell dual-color imaging. Live imaging was performed on cysts in eight-well
chamber slides (Labtek II, Nunc). Cysts co-expressing EGFP-2xPH-TAPP1 and
either TagRFP-T-Rab11a or Membrane-tdTomato were imaged on an inverted
spinning-disk confocal microscope system (Yokogawa/Zeiss) with a 37 °C and 5%
CO2 controlled environment (Zeiss) and heated stage (PECON) through a 20 ×
1.49NA lens (Zeiss), using 488/561 nm laser lines. Images were captured via an
AxioCam Mrm (Zeiss). A stack of three images at 5 µm intervals was taken using
an automated stage controlled via the ZEN software package (Zeiss). As cysts
develop and move during image acquisition, the optimal focal plane was manually
chosen for each time point post-acquisition from the stacked images, before
compilation of image series of each movie. Movies and images were processed
using ImageJ (NIH), as adapted from Stehbens et al.45. Brieﬂy, the functions
‘Remove Outliers’ (radius, 2; threshold, 5), and ‘Unsharp Mask’ (radius, 7; mask,
0.5) were applied to improve image contrast.
RNAi. Lentiviral shRNAs were used to stably deplete proteins, described in Virus
production and transduction methods section. ShRNA sequences were generated
using iRNA software, as per Addgene (https://www.addgene.org/tools/protocols/
plko/). RNAi target sequences are listed in Supplementary Table 2. Knockdown
was veriﬁed by western blot or RT-qPCR procedures, normalized to GAPDH
expression. Due to the canine origin of MDCK, shRNAs were custom-designed,
and RNAi sequences chosen not to match human were utilized when rescuing with
transgenes.
RT-qPCR. For detection of phosphoinositide kinases and phosphatases expression
or for shRNA-mediated knockdown veriﬁcation, RT-qPCR was used. Primers were
designed based on the canine genome using Primer3Plus software and are listed in
Supplementary Table 3. RT-qPCR was performed using EXPRESS One-Step
SYBR® GreenER™ Universal (Thermo Fisher Scientiﬁc) per manufacturer’s
instructions.
Virus production and transduction. All lentiviruses were derived from the
pLKO backbone. Plasmids were either co-transfected with Virapower packaging
mix (Invitrogen) or co-transfected with pSPAX2 and pVSVG packaging plas-
mids, both using Lipofectamine 2000 into 293-FT cells according to manufac-
turer's instructions (Invitrogen). Viral supernatants were collected 2 and 3 days
after transfection, then clariﬁed of cell debris using PES 0.45 µm syringe ﬁlters
(Starlab) and concentrated using Lenti-X concentrator (Takara), following
manufacturer’s instructions. For retroviruses, viral supernatants were collected
daily from days 5 to 7 after transfection of 293-GPG packaging cells. After
centrifugation twice at 3500×g to remove cell debris, supernatants were snap-
frozen in liquid nitrogen. For lentiviral transductions, MDCK cultures
18 h after plating were infected with viral supernatants for 12–16 h at 37 °C.
Next, supernatants were diluted 1:1 with growth medium, cultured for a further
48 h at 37 °C, then passaged into appropriate antibiotic-containing medium. For
retroviral transductions, cells 12–16 h post plating were incubated with viral
supernatants supplemented with 10 μg ml−1 Polybrene (Millipore) for 24 h at
Fig. 5 Regulation of PIP3 basolateral levels is essential for de novo lumen formation. a Representative picture of cysts overexpressing speciﬁed PIP
reporters. b–d Quantitation of relative basolateral to total b, apical to cytoplasm c, or apical to basolateral d PIP reporter intensity. All conditions are Log2
ratios normalized to GFP-overexpressing control MDCK cells, after treatment with either control (EtOH) or SHIP1 inhibitor. Box-and-whiskers: 10–90
percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles. n≥ 267 cysts assessed from three replicate wells/condition/experiment, from
three independent experiments. P-values: One-way ANOVA. **P≤ 0.005. e, f Quantitation of cysts displaying single lumen e or inverted polarity f after
treatment with either control (DMSO+ EtOH), SHIP1 inhibitor (SHIP1-i) and/or PI3K inhibitor (PI3K-i). Values are presented as a fold-change upon
control. Box-and-whiskers: 10–90 percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles. n≥ 4000 cysts assessed from 2 to 3 replicate
wells/condition/experiment, from four independent experiments. P- values: Mann–Whitney test. *P≤ 0.05, **P≤ 0.005, ***P≤ 0.0001. g Representative
images of cysts from e to f stained for Podxl (inverted greyscale). Scale bars, 50 µm. h Quantitation of average object area in treatments from e to f. n≥
4000 cysts, 2–3 replicate wells/condition/experiment, four independent experiments. Box-and-whiskers: 10–90 percentile; +, mean; dots, outliers;
midline, median; boundaries, quartiles. P-values: One-way ANOVA. *P≤ 0.05, **P≤ 0.005, ***P≤ 0.0001. i Quantitation of either control or SHIP1-
inhibited (SHIP1 inhibitor) single lumen (left) or inverted polarity (right) phenotypes, without or with histone carrier, with unlabeled or Bodipy-labeled PI
(3,4)P2. Values are fold change to control. Box-and-whiskers: 10–90 percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles. n≥ 2500
cysts assessed from three replicate wells/condition/experiment, from three independent experiments. P-values: One-way ANOVA. *P≤ 0.05, **P≤ 0.005,
***P≤ 0.0001
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32 °C. Upon changing to fresh medium, cells were incubated for a further 48 h
at 37 °C, before passage into appropriate antibiotic-containing medium.
Hygromycin (0.5 mg ml−1), blasticidin (12.5 μg ml−1), puromycin (5 μg ml−1),
or zeocin (0.4 mg ml−1) were used.
Plasmids and cell lines. The sources of stable cell lines or plasmids are: GFP-
Rab11a12; GFP-PH-PLC11; GFP-PH-Grp1 (M. Birnbaum, University of
Pennsylvania, USA); GFP-PH-Akt46; GFP-2xFYVE(Hrs) (H. Stenmark, The
Norwegian Radium Hospital, Norway); pEGFP-C1-P4M-SidM (Addgene
Plasmid 51469), GFP-PH-FAPP1, GFP-OSH2-PH, GFP-OSH2-2xPH (T. Balla,
NIH, USA); GFP-PH-ING2 (J. Yuan, Harvard Medical School, USA); GFP-PH-
TAPP1 (D. Alessi, University of Dundee, UK); GFP-Cavin-1 (R. Parton,
University of Queensland, Australia); GFP-Tubby-C (L. Shapiro, Columbia
University, USA); GFP-PIK3C2A and GFP-PIK3C2B (V. Haucke, FMP, Ger-
many); OCRL1-mCherry (Addgene plasmid 27675); SNX9-mCherry (Addgene
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plasmid 27678), EGFP-CDC42 WT, EGFP-CDC42Q61L, T23 PBD-YFP, GFP-
Annexin211,12.
The following additional plasmids were generated through site-directed
mutagenesis (Quikchange, Agilent) or standard subcloning: GFP-2xPH-TAPP1,
eGFP-2xPH-TAPP1 R211L, EGFP-CDC42Q61L, TagRFPT-Rab11a (WT) in
pQCXIH, mCherry-SNX9 KR (K267N, R327N), mCherry-SNX9 RYK (R286A,
Y287A, K288A), mCherry-INPP4B (WT and C842A) in pmCherry-C1, SGFP2-
INPP5E in pSGFP2-C1 (Addgene Plasmid 22881) and in pRevTRE (Clontech),
INPP5D-EGFP (WT and D673G) in pEGFP-N1. The complementary DNA
templates for INPP5E, INPP4B and INPP5D were from Thermo Scientiﬁc (clone
ID 5242186), Addgene plasmid 24324 and GE Healthcare (clone ID 8322634),
respectively. For Membrane-tdTomato, the puromycin resistance cassette from
pLKO-puro-Scramble, was replaced with Membrane-tdTomato (from Addgene
plasmid 37351).
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Fig. 7 INPP4A/B negatively regulate apical polarization. a Analysis of parental MDCK or INPP4B WT or phosphatase-dead (CA, C842A) by western blot,
showing INPP4B and β-tubulin expression. b Representative confocal images, cysts stained for Podxl (red), β-catenin (green) and nuclei (blue). mCherry
(red). Note defective lumen formation, and subcortical Podxl accumulation upon INPP4B expression, but not the C842A mutant. Scale bars, 10 µm.
c Phenotype quantitation without or with overexpression of WT or phosphatase-defective INPP4B. Mean ± s.d., n≥ 300 cysts assessed from three wells/
condition/experiment, three independent experiments. P-values: two-way ANOVA. ***P≤ 0.0001. d Downregulation of INPP4A/B by shRNA. RNA
extracts from MDCK cells stably expressing scramble or shRNA targeting the corresponding gene were analyzed by RT-qPCR. Mean ± s.d., n= three
replicate wells/condition, from one experiment. P-values: One-way ANOVA. *P≤ 0.05. e, f Quantitation f of single lumen formation in 48 h control (EtOH)
cysts stably expressing either scramble or INPP4A/B shRNAs, alone or in combination, and repeated in SHIP1-inhibited conditions (SHIP1-i) and
representative images of Podxl staining from these condition (e, Podxl in inverted greyscale; scale bars, 50 µm). Values are fold change to control. Plots are
box-and-whiskers: 10–90 percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles. n≥ 2000 cysts assessed from three replicate wells/
condition/experiment, three independent experiments. P-values, Mann–Whitney test: *P≤ 0.05, **P≤ 0.005
Fig. 6 Class-II PI3-kinases regulate lumen formation. a Downregulation of PIK3C2A, PIK3C2B and PIK3C2G by shRNA. RNA extracts from MDCK cells stably
expressing scramble or shRNA targeting the corresponding gene were analyzed by RT-qPCR. Mean ± s.d., n= 3 wells/condition, from one experiment. P-
values: One-way ANOVA. *P≤ 0.05, ***P≤ 0.0001. b, c Quantitation of single lumen formation in cysts (48 h) stably expressing either scramble or
PIK3C2A/B/G shRNAs alone or in combination b and representative images of Podxl staining from these condition (c, Podxl in inverted greyscale; scale bars,
50 µm). Values are fold change to control. Box-and-whiskers: 10–90 percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles. n≥ 1900
cysts assessed from three replicate wells/condition/experiment, from two independent experiments. P-values: One-way ANOVA. *P≤ 0.05, **P≤ 0.005,
***P≤ 0.0005. d–f MDCK cysts stably expressing GFP-PIK3C2A or GFP-PIK3C2B (green), stained for Rab11a (red) at indicated polarity stages. Magenta
arrowheads, PIK3C2A/B overlapping with Rab11a vesicles. Yellow arrows, Rab11a-negative, PIK3C2A/B punctate localization. White arrowheads, basolateral
PIK3C2B. White arrows, Rab11 positive vesicles. Scale bars, 10 µm. g Quantitation of polarity phenotypes in control (EtOH) or SHIP1 inhibitor-treated (SHIP1-
i) parental (MDCK) cysts, or stably expressing GFP-PIK3C2A or GFP-PIK3C2B. Box-and-whiskers: 10–90 percentile; +, mean; midline, median; boundaries,
quartiles. PIK3C2A, n≥ 1550 cysts assessed from three replicate wells/condition/experiment, two independent experiments. P-values, Mann–Whitney test:
*P≤ 0.05, **P≤ 0.005. PIK3C2B, n≥ 800 cysts assessed from 2 to 3 replicate wells/condition/experiment, three independent experiments
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Fig. 8 The apical Par complex is PI(3,4)P2-independent. a Left, total cell lysates of 3D MDCK cysts upon treatment with SHIP1 inhibitor or ethanol as
control, western blotted for total or phospho-aPKC (pT410), and GAPDH. Right, quantitation of normalized band intensity across experimental replicates.
Mean ± s.d., n= 3, P-value, Mann–Whitney test. n.s. stands for non-signiﬁcant. b Forty-eight hours MDCK cyst stably overexpressing GFP-Anx2 (green)
treated with either ethanol (control) or SHIP1 inhibitor, stained for Podxl (red) and nuclei (blue). White arrows, apical membrane. White arrowheads,
lateral domain. Scale bars, 10 µm. c Quantitation of apical to cytoplasm (left), plasma membrane to cytoplasm (center) or apical to basolateral (right) GFP-
Anx2 relative intensity in control (Ethanol, EtOH) or SHIP1-inhibited (SHIP1-i) conditions. All conditions are Log2 ratios normalized to control cysts.
Box-and-whiskers: 10–90 percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles. n≥ 37 cysts per condition, assessed from one
experiment. d Twenty-hour or 48 h MDCK cysts stably co-overexpressing GFP-Cdc42 (green) and TagRFPT-Rab11a (red) in control (EtOH) or
SHIP1-inhibited conditions, stained for Podxl (blue). White arrows, Rab11a/Cdc42 co-localization. White arrowheads, basolateral. Scale bars, 10 µm.
e, f Quantitation of relative apical to cytoplasm (left), plasma membrane to cytoplasm (center), or apical to basolateral (right) intensity of MDCK cysts
stably expressing either PBD-YFP e or GFP-Cdc42 (WT or Q61L mutant, f) in control (EtOH) or SHIP1-inhibited (SHIP1-i) conditions. All conditions are
Log2 ratios normalized to control cysts. Box-and-whiskers: 10–90 percentile; +, mean; dots, outliers; midline, median; boundaries, quartiles. n≥ 34 cysts
per condition, assessed from one experiment. P-value, Mann–Whitney test. **P≤ 0.005, ***P≤ 0.0001
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Fig. 10 Model of PIP rearrangements during lumen formation. Shortly after plating into 3D, single MDCK cells undergo morphogenesis to form a cell doublet with
initially inverted polarity a, whereby the apical surface marked by Podxl abuts the ECM. At this stage, a PI(4)P>PI(4,5)P2 > PIP3 cascade deﬁnes the cell–cell
contact, while PI(3,4)P2 is inverted. b To reorient polarity, peripheral Podxl internalizes into vesicles which are initially PI(3)P and/or PI(4)P positive, before
progressively enriching to become PI(3,4)P2/Rab11a-positive. These vesicles target to the apical membrane initiation site (AMIS). The PI(3,4)P2-promoting Class-II
PI3Ks PIK3C2A/B promote, whereas the PI(3,4)P2-degrading phosphatases INPP4A/B inhibit, this process. Concomitantly, the AMIS is formed by two PIP
phosphatases, PTEN and SHIP1, which focally convert PIP3 into, PI(4,5)P2 or PI(3,4)P2, respectively to form this zone for apical vesicle delivery. c Upon delivery of
transcytosing Podxl, de novo lumen formation is completed, leaving cortical PI(4)P and PI(4,5)P2, basolateral PIP3, and apical and recycling endosome PI(3,4)P2
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Immunoblotting. Protein blotting was adapted from previous protocols13. Ice-cold
extraction buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5 mM MgCl2, 0.2 mM
EGTA, and 1% Triton X-100 plus 50 mM NaF, 1 mM Na3VO4 and complete
protease inhibitor cocktail tablet (Roche, Mannheim, Germany)) on ice for 5 min
was used for cell solubilization. Cells were then scrapped and passed through a 27½
-gauge needle before extraction at 4 °C for 25 min. Clariﬁcation of post-nuclear
supernatants was performed by centrifugation at 14,000 × g at 4 °C for 10 min.
SDS-PAGE was used to separate samples, followed by transfer to PVDF mem-
branes. Western analysis was performed using either chemiluminescence (Super-
Signal Chemiluminescence Kit; Pierce, Rockford, IL) or infrared ﬂuorescent
secondary antibodies and quantitative detection (Odyssey CLx, Li-COR Bios-
ciences). A BCA Protein Assay Reagent kit (Pierce) was used to determine protein
concentration. Transfer and protein loading were monitored by staining 0.1%
Coomassie Brilliant Blue. Statistical analysis of western blots and generation of
accompanying graphs were performed using Excel (Microsoft) or Prism (Graph-
pad). Uncropped membranes are presented in Supplementary Figure 5.
Delivery of exogenous PI(3,4)P2. Exogenous PIP was delivered to cysts as pre-
viously reported11 with appropriate adaptations: PI(3,4)P2 and Histone carriers
(Shuttle PIPTM, Echelon, Salt Lake City, UT) were freshly prepared in PIP solution
(150 mM NaCl, 4 mM KCl, 20 mM HEPES at pH 7.2) to a ﬁnal concentration of
300 or 100 µM, respectively. Complexes were combined for 10 min, and diluted
1:10 in Hank’s buffered salt solution, solution added for 30 min to MDCK cysts
that had previously been cultured in 3D for 48 h. Cells were ﬁxed, stained, and
imaged.
Repeatability of experiments. Immunoﬂuorescence images of 3D MDCK cysts:
representative image from one ﬁeld of ~1 × 104 cells in shown. Each experiment
was repeated at least twice unless otherwise indicated.
Immunoﬂuorescence images of MDCK cells grown in Transwell: representative
image from two image sets.
Movies: Representative movie from ﬁve movies of single lumen MDCK cysts.
Western blot:
Figure 4f: representative image from two blots.
Figure 7a: blot, performed one time
Figures 9c, f: representative image from three blots.
Figure 8a: representative image from three blots.
Supplementary Figure 1b: representative image from two blots.
Polarity analysis (Manual or PAPA):
Figure 4d: Left, three wells/condition/experiment, four independent
experiments, manual analysis. Right, three wells/condition, three independent
experiments, PAPA analysis.
Figure 4g: Four wells/condition/experiment, manual analysis.
Figure 5e, f, h: 2–3 wells/condition/experiment, four independent experiments,
PAPA analysis.
Figure 5i: Three wells/condition/experiment, three independent experiments,
PAPA analysis.
Figure 6b: Three wells/condition/experiment, two independent experiments,
PAPA analysis.
Figure 6g: 2–3 wells/condition/experiment, 2 or 3 independent experiments,
PAPA analysis.
Figure 7c: Three wells/condition/experiment, three independent experiments,
manual analysis.
Figure 7f: three wells/condition/experiment, three independent experiments,
PAPA analysis.
Supplementary Figure 1c. Three wells/condition/experiment, one experiment,
left manual, right PAPA analysis.
Supplementary Figure 3h: Three wells/condition/experiment, ﬁve independent
experiments, manual analysis.
PAPI analysis:
Figure 2c: Three wells/condition/experiment, 2–3 independent experiments
Figure 5b–d: Three wells/condition/experiment, Three independent
experiments
Figure 8c, e, f: ≥25 independent objects/condition, one independent experiment.
Data availability
All relevant data are available from the authors upon request.
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